Executive Moves | Healthcare | BioTuesdays by Kilmer Lucas IR

Executive Moves

Murat Omur joins Ladenburg Thalmann as managing director in healthcare IB

Ladenburg Thalmann has announced the appointment of Murat Omur as managing director in the healthcare investment banking division. With 17 years of investment banking experience in healthcare and the M&A sector, Mr...

October 15, 2024

Executive Moves

MaxCyte appoints Ali Soleymannezhad as CCO

MaxCyte (NASDAQ:MXCT; LSE:MXCT) has appointed Ali Soleymannezhad as chief commercial officer, effective September 11, 2024. Prior to this role, Mr. Soleymannezhad served as executive vice president of bioprocessing at...

October 10, 2024

Executive Moves

Therma Bright adds pharma veteran Douglas S. Sommerville to AB

Therma Bright (TSXV: THRM; OTCQB: TBRIF), has announced the addition of Douglas S. Sommerville to its advisory board. In a statement, Rob Fia, CEO of Therma Bright, said, “Doug is highly respected across North...

September 12, 2024

Executive Moves

Creyon Bio appoints venture capitalists Serge Messerlian and Shaquille Vayda to board

Creyon Bio has appointed two prominent venture capitalists, Serge Messerlian, operating partner at DCVC Bio, and Shaquille Vayda, principal at Lux Capital, to its board. “We are excited to welcome Serge and Shaq...

September 10, 2024

Executive Moves

MOBILion appoints Rohit Khanna to BOD

Closely-held MOBILion Systems has announced the appointment of seasoned life sciences executive, Rohit Khanna, Ph.D., to its board, effective immediately. Dr. Khanna co-founded software engineering firm Dynamic...

August 28, 2024

Executive Moves

ANEW Medical appoints Jeffrey LeBlanc as CFO

ANEW Medical (NASDAQ:WENA) announced the appointment of Jeffrey LeBlanc as its new CFO, succeeding interim CFO, Edward Cong Wang, the former CFO of Redwoods Acquisition, which ANEW merged with. ANEW’s portfolio includes...

August 19, 2024

Executive Moves

Carisma Therapeutics expands SAB with renowned KOLs

Carisma Therapeutics (NASDAQ:CARM) has appointed Drs. Scott Friedman and Ira Tabas to its scientific advisory board (SAB). “It is an honor to welcome Dr. Friedman and Dr. Tabas to our SAB,” said Steven...

August 6, 2024

Executive Moves

Cantargia names Ton Berkien as CBO

Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) announced the recruitment of Ton Berkien as Chief Business Officer effective October 1. Mr. Berkien joins the management team at Cantargia with approximately 30 years of...

June 11, 2024

Executive Moves

Sigyn Therapeutics names Jerry DeCiccio as CFO

Sigyn Therapeutics (OTCQB:SIGY) appointed Jerry DeCiccio as CFO, succeeding Jeremy Farrell, who was appointed CFO in March of 2022. Mr. DeCiccio has more than 40 years of financial industry experience, previously...

December 12, 2023

Executive Moves

SAB Biotherapeutics names Michael G. King Jr. as CFO

SAB Biotherapeutics (NASDAQ:SABS) appointed Michael G. King Jr. as CFO, effective Oct 30. Mr. King replaces Russell Beyer, who is expected to step down on Nov. 15 and remain a senior advisor with the company for the...

October 25, 2023

Executive Moves

Mati promotes Chris Muller to COO

Closely-held Mati Therapeutics named Chris Muller as COO, effective immediately. Most recently Mati’s CCO, Mr. Muller’s expanded responsibilities include overseeing all operating activities; and preparing for and...

September 28, 2023

Executive Moves

Aurinia appoints Hepion’s Dr. Robert T. Foster to board

Aurinia Pharmaceuticals (NASDAQ:AUPH) appointed Dr. Robert T. Foster, CEO of Hepion Pharmaceuticals, to its board. “As the doctor who discovered voclosporin, and Aurinia’s founder, [Dr. Foster] has a wealth of...

September 21, 2023

Executive Moves

Enzo Biochem names Kara Cannon as interim CEO

Enzo Biochem (NYSE:ENZ) appointed its chief operating officer, Kara Cannon, to be interim CEO after Hamid Erfanian, former CEO, left the company, effective Sept. 5. Mr. Erfanian led the company through the sale of Enzo...

September 6, 2023

Executive Moves

Zoe Heineman joins Hygieia as VP of BD

Closely-held Hygieia, a provider of digital therapeutics for insulin management, hired Zoe Heineman as VP of business development. Ms. Heineman brings more than 30 years of expertise in strategic leadership, operations...

September 1, 2023

Executive Moves

Veteran investment banker Jed Cohen joins Raymond James

Seasoned investment banker Jed Cohen has joined Raymond James as a managing director of its healthcare investment banking practice. The strategic hire underscores the firm’s continuing commitment to expanding the sector...

July 14, 2023

Executive Moves

Former Pfizer vaccine president Nanette Cocero joins PharmaJet board

PharmaJet appointed Nanette Cocero, Ph.D., a recognized leader in the global pharmaceutical industry with broad commercial and business experience coupled with an extensive clinical and scientific background, to the...

July 12, 2023

Executive Moves

Marie Mazur appointed chair of PharmaJet board

PharmaJet named Marie Mazur, PharmD, chairwoman of the board, replacing Ron Lowy, who had chaired the board since 2011. “Marie’s experience and leadership will be of great benefit for our company as we are accelerating...

June 6, 2023

Executive Moves

Theralase appoints internationally accomplished biopharma Executive, Dr. Kaouthar Lbiati, as independent board director

Theralase Technologies (TSXV:TLT; OTCQB:TLTFF) appointed Kaouthar Lbiati, M.D., as an independent director. Dr. Lbiati received a post-doctorate in clinical oncology from Gustave Roussy Institute in Paris, which is a...

June 6, 2023

Executive Moves

Perimeter Medical names Adrian Mendes as CEO; appoints Dr. Josh Vose to board

The board of Perimeter Medical Imaging AI (TSXV:PINK; OTC:PYNKF; FSE:4PC) appointed Adrian Mendes as CEO, effective immediately, succeeding Jeremy Sobotta, who has resigned for personal reasons, effective June 15, 2023...

June 5, 2023

Executive Moves

Ondine Biomedical names Simon Sinclair as CMO

Ondine Biomedical (LON:OBI) appointed Simon Sinclair, M.D., Ph.D., as chief medical officer, as the company prepares to start a U.S. Phase 3 trial of its nasal photodisinfection technology. Dr. Sinclair has more than 20...

June 1, 2023

Executive Moves

Theralase names Roger DuMoulin-White as president and CEO

Theralase Technologies (TSXV:TLT; OTCQB:TLTFF) appointed Roger DuMoulin-White as president and CEO, succeeding Arkady Mandel, M.D., Ph.D., as interim CEO. Dr. Mandel will continue as CSO and a director. Mr. DuMoulin...

May 25, 2023

Executive Moves

Conavi Medical names CV device veteran Brian Chambless as CCO

Conavi Medical appointed accomplished cardiovascular medical device industry veteran, Brian Chambless, to the newly created position of chief commercial officer (CCO). In an executive management career spanning more...

May 15, 2023

Murat Omur joins Ladenburg Thalmann as managing director in healthcare IB

MaxCyte appoints Ali Soleymannezhad as CCO

Therma Bright adds pharma veteran Douglas S. Sommerville to AB

Creyon Bio appoints venture capitalists Serge Messerlian and Shaquille Vayda to board

MOBILion appoints Rohit Khanna to BOD

ANEW Medical appoints Jeffrey LeBlanc as CFO

Carisma Therapeutics expands SAB with renowned KOLs

Cantargia names Ton Berkien as CBO

Sigyn Therapeutics names Jerry DeCiccio as CFO

SAB Biotherapeutics names Michael G. King Jr. as CFO

Mati promotes Chris Muller to COO

Aurinia appoints Hepion’s Dr. Robert T. Foster to board

Enzo Biochem names Kara Cannon as interim CEO

Zoe Heineman joins Hygieia as VP of BD

Veteran investment banker Jed Cohen joins Raymond James

Former Pfizer vaccine president Nanette Cocero joins PharmaJet board

Marie Mazur appointed chair of PharmaJet board

Theralase appoints internationally accomplished biopharma Executive, Dr. Kaouthar Lbiati, as independent board director

Perimeter Medical names Adrian Mendes as CEO; appoints Dr. Josh Vose to board

Ondine Biomedical names Simon Sinclair as CMO

Theralase names Roger DuMoulin-White as president and CEO

Conavi Medical names CV device veteran Brian Chambless as CCO

General

More